- Home
- PROK vs AKYA Comparison
PROK vs AKYA Comparison
Compare PROK & AKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- AKYA
- Stock Information
- Founded
- PROK 2015
- AKYA 2015
- Country
- PROK United States
- AKYA United States
- Employees
- PROK N/A
- AKYA N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- AKYA Medical Specialities
- Sector
- PROK Health Care
- AKYA Industrials
- Exchange
- PROK Nasdaq
- AKYA Nasdaq
- Market Cap
- PROK 186.8M
- AKYA 152.2M
- IPO Year
- PROK N/A
- AKYA 2021
- Fundamental
- Price
- PROK $1.05
- AKYA $1.59
- Analyst Decision
- PROK Buy
- AKYA Buy
- Analyst Count
- PROK 5
- AKYA 7
- Target Price
- PROK $4.50
- AKYA $4.40
- AVG Volume (30 Days)
- PROK 546.9K
- AKYA 369.0K
- Earning Date
- PROK 03-21-2025
- AKYA 03-21-2025
- Dividend Yield
- PROK N/A
- AKYA N/A
- EPS Growth
- PROK N/A
- AKYA N/A
- EPS
- PROK N/A
- AKYA N/A
- Revenue
- PROK N/A
- AKYA $86,815,000.00
- Revenue This Year
- PROK N/A
- AKYA N/A
- Revenue Next Year
- PROK N/A
- AKYA $11.90
- P/E Ratio
- PROK N/A
- AKYA N/A
- Revenue Growth
- PROK N/A
- AKYA N/A
- 52 Week Low
- PROK $0.98
- AKYA $1.43
- 52 Week High
- PROK $4.44
- AKYA $5.26
- Technical
- Relative Strength Index (RSI)
- PROK 23.63
- AKYA 26.97
- Support Level
- PROK $0.98
- AKYA $1.43
- Resistance Level
- PROK $1.32
- AKYA $1.69
- Average True Range (ATR)
- PROK 0.11
- AKYA 0.14
- MACD
- PROK -0.04
- AKYA -0.02
- Stochastic Oscillator
- PROK 10.61
- AKYA 17.02
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.